Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration

GLIA

Volumn 27, Issue 2, 1999, Pages 110-128

  Stephenson, Diane ^a,b   Rash, Karen ^b   Smalstig, Barry ^b   Roberts, Edda ^b   Johnstone, Edward ^b   Sharp, John ^b   Panetta, Jill ^b   Little, Sheila ^b   Kramer, Ruth ^b   Clemens, James ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Astrocytes; Axotomy; Inflammation; Ischemia; Microglia; PDAPP; Phospholipase A2

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ISOENZYME; NERVE PROTEIN; PHOSPHOLIPASE A; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; BRAIN ISCHEMIA; COMPARATIVE STUDY; CYTOSOL; DISEASE MODEL; ENZYME INDUCTION; ENZYMOLOGY; FACIAL NERVE INJURY; FOREBRAIN; GENETICS; GLIA; GLIOSIS; HUMAN; INFLAMMATION; MALE; MICROGLIA; MOTOR NEURON DISEASE; MOUSE; NERVE DEGENERATION; PATHOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE; VASCULARIZATION; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CYTOSOL; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; FACIAL NERVE INJURIES; GLIOSIS; HUMANS; INFLAMMATION; ISOENZYMES; MALE; MICE; MICE, TRANSGENIC; MICROGLIA; MOTOR NEURON DISEASE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROGLIA; PHOSPHOLIPASES A; PROSENCEPHALON; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 0032588897     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C     Document Type: Article

References (112)

1. Agarwal ML, Larkin HE, Zaidi SI, Mukhtar H, Oleinick NL. 1993. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res 53:5897-5902.
2. Arvin B, Neville LF, Barone FC, Feuerstein GZ. 1995. Brain injury and inflammation; a putative role of TNFα. Ann. NY Acad Sci 765:62-71.
3. 2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci 11:117-123.
4. Barger SW, Horster D, Furukawa K, Goodman Y, Drieglestein J, Mattson MP. 1995. Tumor necrosis factors α and β protect neurons against amyloid β-toxicity: evidence for involvement of a kB-binding factor and attenuation of peroxide and Ca+ + accumulation. Proc Natl Acad Sci USA 92:9328-9332.
5. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ. 1997. Tumor necrosis factor-α, a mediator of focal ischemic brain injury. Stroke 28:1233-1244.
6. Bazan NG, Morelli de Liberti SM, Rodriguez de Turco EB. 1982. Arachidonic acid and arachidonoyl-diglycerides increase in rat cerebrum during bicuculline-induced status epilepticus. Neurochem Res 7:839-843.
7. Benveniste EN. 1992. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263:C1-C16.
8. Bignami A, Dahl D. 1974. Astrocyte-specific protein and radial glia in the cerebral cortex of newborn rat. Nature 252:55-56.
9. 2 activity, reduces functional deficits after global ischemia in rats. Br Res Bull 36:257-260.
10. 2. Nature 390:622-625.
11. Brint S, Jacewica M, Kiessling M, Tanabe J, Pulsinelli W. 1988. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8:474-185.
12. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. 1986. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17:738-743.
13. Chiu EKY, Richardson JS. 1985. Behavioural and neurochemical aspects of prostaglandins in brain function. Gen Pharmacol 16:163-175.
14. Choi DW. 1996. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6:667-672.
15. Clemens JA, Saunders RD, Ho PP, Phebus LA, Panetta J. 1993. The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke 24:716-723.
16. 2 after transient global forebrain ischemia in the rat. Stroke 27:527-535.
17. Clemens JA, Stephenson DT, Smalstig EB, Dixon EP, Little SP. 1997. Global ischemia activates nuclear factor-kB in forebrain neurons of rats. Stroke 28:1073-1081.
18. Dal Canto MC, Gurney ME. 1994. The development of CNS pathology in a murine transgenic model of human ALS. Am J Pathol 145:1271-1279.
19. Dani JW, Chernjavsky A, Smith SJ. 1992. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron 8:429-440.
20. 2 superfamily of signal transduction enzymes. Trends Biochem Sci 253:1-2.
21. Dijkstra CD, Doepp EA, Joling P, Draal G. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognised by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589-599.
22. Dubois-Dauphin M, Frankowski H, Tsujimoto Y, Huarte J, Martinou JC. 1994. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci USA 91:3309-3313.
23. Dumuis A, Sebben M, Haynes L, Pin J-P, Bockaert J. 1988. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336:68-70.
24. 2 in brain during ischemia. J Neurochem. 39:1111-1116.
25. 2 activity is required for regeneration of sensory axons in cultured adult sciatic nerves. J Neurosci Res 43:183-189.
26. 2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion. Brain Res 752:203-208.
27. Farooqui AA, Horrocks LA. 1994. Involvement of glutamate receptors, lipases, and phospholipases in long-term potentiation and neurode-generation. J Neurosci Res 38:6-11.
28. 2 and its role in brain tissue. J Neurochem 69:889-901.
29. 2 in the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositol phospholipid hydrolysis. Proc Natl Acad Sci USA 87:2187-2191.
30. Fierz W, Fontana A. 1986. The role of astrocytes in the interaction between the immune and nervous system. In Fedoroff S, Vernadakis A, editors. Astrocytes vol. 3. New York: Academic Press, p 203-230.
31. Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J. 1997. Inhibition of ICE slows ALS in mice. Nature 388:31.
32. Games D, Adams D, Alessandrini R, et al. 1995, Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
33. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann K-A, Kreutzberg GW. 1992. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 12:257-269.
34. Graeber MB, Kreutzberg GW. 1988. Delayed astrocyte reaction following facial nerve axotomy. J Neurocytol 17:209-220.
35. 2 activity from the 106,000 × g pellet (microsomal fraction) of bovine brain acting on phosphotidylinositol. Can J Biochem 60:108-117.
36. Gurney M, Pu H, Chiu AY, et al. 1994. Motor neuron degeneration in mice that express a human Cu-Zn superoxide dismutase mutation. Science 264:1772-1775.
37. Hall ED, Oostveen JA, Gurney ME. 1998. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256.
38. 2+ ionophore-induced apoptosis in cultured rat cortical neurons. Biochem Biophys Res Commun 227:513-518.
39. 2 from bovine brain cytosol. J Neurochem 59:708-714.
40. Holtsberg FW, Steiner MR, Keller JN, Mark RJ, Mattson MP, Steiner SM. 1998. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons. J Neurochem 70:66-76.
41. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT. 1997a. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17:7053-7059.
42. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. 1997b. APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965-973.
43. Ito S, Sugama K, Inagaki N, Fukui H, Giles H, Wada H, Hayaishi O. 1992. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2 and F2 alpha. Glia 6:67-74.
44. 2 in breast carcinoma cells. Oncogene 10:2297-2305.
45. Katsuki H, Okuda S. 1995. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol. 46:607-636.
46. Kim D, Clapham DE. 1989. Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science 244:1174-1176.
47. Kim I, Lee JW, Sohn H-W, Kim H-S, Kim S-H. 1993. Prostaglandin A2 and 12-prostaglandin J2 induce apoptosis in L1210 cells. FEBS Lett 321:209.
48. Kimura H, Okamoto K, Sakai Y. 1985. Modulatory effects of prostaglandin D2, E2 and F2alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro. Brain Res 330:235-244.
49. 2 are resistant to MPTP neurotoxicity. J Neurochem 71:2634-2637.
50. Koller M, Wachtler P, David A, Muhr G, Konig W. 1997. Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes. Inflammation 21:463-474.
51. Kostic V, Gurney M.E, Deng H-X, Siddique T, Epstein CJ, Przedborski S. 1997a. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 41:497-504.
52. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. 1997b. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277:559-562.
53. 2. In: Pruzanski W, Vadas P, editors. Novel molecular approaches to anti-inflammatory therapy. Basel: Birkhauser Verlag.
54. 2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 266:5268-5272.
55. 2) in human platelets. J Lipid Mediat Cell Signal 6:209-216.
56. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. TINS 19:312-318.
57. Lavine SD, Hofman FM, Zlokovic BV. 1998. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J Cereb Blood Flow Metab 18:52-58.
58. Le W-D, Colom LV, Xie W-J, Smith RG, Alexianu M, Appel SH. 1995. Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 686:49-60.
59. Linnik MD. 1996. Role of apoptosis in acute neurodegenerative disorders. Restor Neurol Neurosci 9:219-225.
60. 2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett 379:77-81.
61. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K. 1997. Activation of NF-kB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein typrosine nitration. J Neurosci Res 49:681-697.
62. Mead JF, Dhopeshwarkar GA, Elepano MG. 1977. Transformations of the polyunsaturated fatty acids in the brain. In: Bazan NG, Brenner RR, Giutso NM, editors. Functions and biosynthesis of lipids. New York: Plenum Press. p 318-328.
63. Murphy S, Pearce B. 1987. Functional receptors for neurotransmitters on astroglial cells. Neuroscience 22:381-394.
64. Murphy S, Pearce B, Jeremy J, Dandona P. 1988. Astrocytes as eicosanoid producing cells. Glia 1:241-245.
65. 2 in axonal regeneration of brain noradrenergic neurons. Neuroreport 4:371-374.
66. 2 activity in neuronal growth cones. J Neurochem 60:1126-1136.
67. 3H] dopamine release from rat tuberoinfundibular neurons. Neuroendocrinology 50:481-487.
68. Okuda S, Saito H, Katsuki H. 1994. Arachidonic acid-toxic and trophic effects on cultured hippocampal neurons. Neuroscience 63:691-699.
69. O'Neill LAJ, Kaltschmidt C. 1997. NF-kB: a crucial transcription factor for glial and neuronal cell function. TINS 20:252-258.
70. Ordway RW, Walsh JVJ, Singer JJ. 1989. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science 244:1176-1179.
71. Ordy JM, Wengenack TM, Bialobok P, Coleman PC, Rodier P, Baggs RB, Dunlap WP, Kates B. 1993. Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Exp Neurol 119:128-139.
72. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ. 1997. Tumor necrosis factor-α: a neuromodulator in the CNS. Neurosci Biobehav Rev 21:603-613.
73. Petito CK, Halaby IA. 1993. Relationship between ischemia and ischemic neuronal necrosis to astrocyte expression of glial fibrillary acidic protein. Int J Dev Neurosci 11:239-247.
74. Petite CK, Morgello S, Felix JC, Lesser ML. 1990. The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab 10:850-859.
75. Prochiantz A, Mallat M. 1988. Astrocyte diversity. Ann NY Acad Sci 540:52-63.
76. Qin Z-H, Wang Y, Nakai M, Chase TN. 1998. Nuclear factor-kB contributes to excitotoxin-induced apoptosis in rat striatum. Mol Pharmacol 53:33-42.
77. Pulsinelli WA. 1985. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 63:29-37.
78. Pulsinelli WA, Brierley JB. 1979. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267-272.
79. Pulsinelli WA, Brierley JB, Plum F. 1982. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498.
80. 2 in vascular smooth muscle cells. Biochim Biophys Acta 1265:67-72.
81. Rathan RR, Murphy TH, Baraban JM. 1994. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 62:376-379.
82. 2 in monocytic cell lines. Biochem J 276:631-636.
83. 2 activity in human brain. J Neurochem 64:2213-2221.
84. 2. Arch Gen Psychiatry 54:487-194.
85. 2 activity in gerbil brain: enhanced activities of cytosolic, mitochondrial and microsomal forms after ischemia and reperfusion. J Neurosci 11:1829-1836.
86. Rossiter JP, Riopelle RJ, Bisby MA. 1996. Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons: time course analysis and relation to NADPH-diaphorase activity. Exp Neural 138:33-44.
87. 2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270:2360-2366.
88. 2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 220:643-647.
89. Sandstrom PA, Pardi D, Tebbey PW, Dudek RW, Terrian DM, Folks TM, Buttke TM. 1995. Lipid hydroperoxide-induced apoptosis: lack of inhibition by Bcl-2 overexpression. FEBS Lett 365:66-70.
90. Schaechter JD, Benowitz LI. 1993. Activation of protein kinase C by arachidonic acid selectively enhances the phosphorylation of GAP-43 in nerve terminal membranes. J Neurosci 13:4361-4371.
91. Schmidt-Kastner R, Szymas J, Hossmann K-A. 1990. Immunohistochemical study of glial reaction and serum-protein extravasation in relation to neuronal damage in rat hippocampus after ischemia. Neuroscience 38:527-540.
92. Schweitzer P, Madamba S, Siggins GR. 1990. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346:464-467.
93. 2 is activated after experimental closed head injury in the rat. J Neurochem 53:1541-1546.
94. Siesjo BK, Ingvar M, Westerberg Z. 1982. The influence of bicuculline-induced seizures on free fatty acid concentrations in cerebral cortex, hippocampus and cerebellum. J Neurochem 39:796-802.
95. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, Li WY. 1994. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373-379.
96. Singh IN, Sato K, Takashima A, Kanfer JN. 1997. Activation of LA-N-2 cell phospholipases by single alanine substitution analogues of amyloid beta peptide (25-35). FEBS Lett 405:65-67.
97. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
98. 2) is expressed in human brain astrocytes. Brain Res 637:97-105.
99. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Disease 3:51-63.
100. Su JH, Anderson AJ, Cummings BJ, Cotman CW. 1994. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533.
101. Tence, M, Cordier J, Glowinski J, Premont J. 1992. Endothelin-evoked release of arachidonic acid from mouse astrocytes in primary culture. Eur J Neurosci 4:993-999.
102. 2 from rat brain. Biochem J 306:305-309.
103. 2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor. J Virol 70:8502-8507.
104. Verkhratsky A, Kettenmann H. 1996. Calcium signaling in glial cells. Trends Neurosci 19:346-352.
105. 2 in human melanoma tumor cells. J. Immunol 156:201-207.
106. 2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 94:5073-5077.
107. Witter B, Kanfer JN. 1985. Hydrolysis of endogenous phospholipids by rat brain microsomes. J Neurochem 44:155-162.
108. 2. FEBS Lett 377:358-362.
109. Wolfe LS. 1982. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 38:1-14.
110. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-1116.
111. 2 from bovine brain. FASEB J 10:A986.
112. 2 activity in rat brain. Biochem Biophys Res Commun 185:350-355.